Targeted Temperature Management

Focused on preserving the brain by maintaining neurological intactment

THE PROBLEM

THE SOLUTION

Targeted Temperature Management and The Brain

TTM is a valuable treatment option for managing elevated intracranial pressure or edema.
TTM is an effective therapeutic option for reducing brain edema, which was proven to improve functional outcome.
Directly cooling the brain has been shown to have fewer side effects compared to whole-body cooling and has been proven to effectively reduce intracranial pressure and suppress neurogenic fevers.

SOLUTION

Cool air for brain temperature

Eliminating effects of pharmaceuticals

Delivered via nasal cavity

On using thermoelectric to cool air and using a gas or air

Published On: October 31, 2024
Med-Tech Pioneer Robert Kline Joins NeuroIntact Inc.’s Board of Directors to Guide Company’s Targeted Temperature Management Technology Toward Commercialization
NeuroIntact Inc., a company pioneering a new modality in targeted temperature management (TTM) to address stroke and traumatic brain injury, has appointed Robert Kline to its Board of Directors.
Read Article
Published On: October 31, 2024
TEDCO Invests in NeuroIntact
TEDCO, Maryland’s economic engine for technology companies, announced a recent $250,000 Seed Funds investment in NeuroIntact.
Read Article
Published On: September 13, 2024
Vivonics, Inc. Awarded $999,962 Contract from USMC for Development of Traumatic Brain Injury Treatment System
Updated consensus guideline recommendations by the Neuroprotective Therapy Consensus Review (NTCR) group.
Read Article

1100 Wicomico Street, Suite 330, Baltimore, MD 21230

For more information reach out to NeuroIntact for assistance, [email protected], or complete the fields below.